0000899243-20-027695.txt : 20201006
0000899243-20-027695.hdr.sgml : 20201006
20201006212700
ACCESSION NUMBER: 0000899243-20-027695
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201006
FILED AS OF DATE: 20201006
DATE AS OF CHANGE: 20201006
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOWNEY BRUCE
CENTRAL INDEX KEY: 0001237257
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39567
FILM NUMBER: 201227954
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: C4 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475617627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 231-0700
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-06
0
0001662579
C4 Therapeutics, Inc.
CCCC
0001237257
DOWNEY BRUCE
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY, SUITE 200
WATERTOWN
MA
02472
1
0
0
0
Common Stock
2020-10-06
4
C
0
237148
A
237148
D
Common Stock
2020-10-06
4
C
0
252394
A
489542
D
Series A Preferred Stock
2020-10-06
4
C
0
2000000
0.00
D
Common Stock
237148
0
D
Series B Preferred Stock
2020-10-06
4
C
0
2128571
0.00
D
Common Stock
252394
0
D
Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.
/s/ Jolie M. Siegel, Attorney-in-Fact
2020-10-06